Comparison

SKLB 1028 European Partner

Item no. TMO-T34656-100mg
Manufacturer TargetMol
CASRN 1350544-93-2
Amount 100 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mg 25 mg 500 mg 50 mg 5 mg
Category
Type Chemicals
Specific against other
Smiles C(C)(C)N1C=2C(N=C1NC=3C=CC=NC3)=CN=C(NC4=CC=C(C=C4)N5CCN(C)CC5)N2
ECLASS 10.1 32160000
ECLASS 11.0 32160000
UNSPSC 12000000
Alias Ruserontinib
Shipping Condition Cool pack
Available
Manufacturer - Targets
EGFR|||FLT|||Bcr-Abl
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
443.55
Description
SKLB 1028 (Ruserontinib) is a new type of oral multikinase inhibitor of EGFR, FLT3, and Abl. SKLB 1028 shows excellent activity in FLT3-driven AML models and considerable potency in CML models containing Abl mutants.
Pathways
Angiogenesis|||Cytoskeletal Signaling|||Tyrosine Kinase/Adaptors|||JAK/STAT signaling

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close